Recall Enforment Report D-0263-2022
Drug Recall Enforcement Report Class III voluntary initiated by Aurobindo Pharma USA Inc., originally initiated on 11-15-2021 for the product Carvedilol Tablets, USP, 6.25 mg, 500 Tablets bottle, Rx Only, Distributed by: Aurobindo Pharma USA Inc., 279 Princeton-Hightstown Road, East Windsor, NJ, 08520, Made in India, NDC 65862-143-05 The product was recalled due to failed impurities/degradation specifications. The product was distributed nationwide and the recall is currently terminated.
Recalled Products
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
65862-142 | Carvedilol | Tablet, Film Coated | Aurobindo Pharma Limited | Drug For Further Processing | ||
65862-142 | Carvedilol | Carvedilol | Tablet, Film Coated | Oral | Aurobindo Pharma Limited | Human Prescription Drug |
65862-143 | Carvedilol | Tablet, Film Coated | Aurobindo Pharma Limited | Drug For Further Processing | ||
65862-143 | Carvedilol | Carvedilol | Tablet, Film Coated | Oral | Aurobindo Pharma Limited | Human Prescription Drug |
65862-144 | Carvedilol | Tablet, Film Coated | Aurobindo Pharma Limited | Drug For Further Processing | ||
65862-144 | Carvedilol | Carvedilol | Tablet, Film Coated | Oral | Aurobindo Pharma Limited | Human Prescription Drug |
65862-145 | Carvedilol | Tablet, Film Coated | Aurobindo Pharma Limited | Drug For Further Processing | ||
65862-145 | Carvedilol | Carvedilol | Tablet, Film Coated | Oral | Aurobindo Pharma Limited | Human Prescription Drug |